CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Financial Officer sold 40,313 shares at an average $49.44 ($1,992,925)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operating Officer sold 35,613 shares at an average $60.13 ($2,141,285)
- 4 Open-market sale General Counsel sold 14,625 shares at an average $60.12 ($879,261)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at an average $60.11 ($1,202,201)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 250,000 shares (grant or award)
- 4 Grant or award General Counsel acquired 70,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 900,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 85,000 shares (grant or award)
Page 24 of 69 · 1,363 filings